| 1 |
33915354 | Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNA. | 2021 Jul |
1 |
| 2 |
31444563 | Clinically feasible method for assessing leukocyte rheology in whole blood. | 2020 Feb |
2 |
| 3 |
32863239 | Myeloperoxidase-derived damage to human plasma fibronectin: Modulation by protein binding and thiocyanate ions (SCN-). | 2020 Sep |
1 |
| 4 |
32865287 | Effect of myeloperoxidase on the anticoagulant activity of low molecular weight heparin and rivaroxaban in an in vitro tumor model. | 2020 Dec |
1 |
| 5 |
29460830 | [Exocytosis of myeloperoxidase from activated neutrophils in the presence of heparin]. | 2018 Jan |
4 |
| 6 |
30237127 | Chlorination and oxidation of human plasma fibronectin by myeloperoxidase-derived oxidants, and its consequences for smooth muscle cell function. | 2018 Oct |
1 |
| 7 |
25867530 | Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure. | 2015 Apr 13 |
1 |
| 8 |
24438360 | Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients. | 2014 Jan 17 |
2 |
| 9 |
24837008 | Effects of enoxaparin on myeloperoxidase release during hemodialysis. | 2014 Oct |
2 |
| 10 |
24976018 | Red blood cells serve as intravascular carriers of myeloperoxidase. | 2014 Sep |
1 |
| 11 |
24267251 | Liberation of vessel-adherent myeloperoxidase reflects plaque burden in patients with stable coronary artery disease. | 2013 Dec |
1 |
| 12 |
22107692 | Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration. | 2011 Dec |
2 |
| 13 |
19049846 | Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function. | 2010 Apr 1 |
3 |
| 14 |
20643239 | Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction. | 2010 Aug 1 |
2 |
| 15 |
19362143 | Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction. | 2009 Jul 1 |
1 |
| 16 |
19524564 | Myeloperoxidase concentrations in EDTA-plasma of healthy subjects are discordant with concentrations in heparin-plasma and serum. | 2009 Sep |
3 |
| 17 |
19961422 | Identification of complexes formed by ceruloplasmin with matrix metalloproteinases 2 and 12. | 2009 Dec |
1 |
| 18 |
18509013 | Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations. | 2008 Jun |
1 |
| 19 |
17525363 | Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils. | 2007 Aug |
3 |
| 20 |
16139336 | Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin. | 2006 |
1 |
| 21 |
16377383 | Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin. | 2006 Jan |
3 |
| 22 |
16464886 | Myeloperoxidase up-regulation during haemodialysis: is heparin the missing link? | 2006 Apr |
1 |
| 23 |
16606792 | Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. | 2006 Apr 18 |
6 |
| 24 |
11742862 | Myeloperoxidase and hypochlorite, but not copper ions, oxidize heparin-bound LDL particles and release them from heparin. | 2001 Dec |
6 |
| 25 |
11958287 | Plasma levels of myeloperoxidase and elastase are differentially regulated by hemodialysis membranes and anticoagulants. | 2000 Nov-Dec |
1 |
| 26 |
10334872 | Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase. | 1999 Jun 1 |
2 |
| 27 |
9655178 | Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. | 1998 Jun |
4 |
| 28 |
9127328 | Active inhibitory effect of nafamostat mesylate against the elevation of plasma myeloperoxidase during hemodialysis. | 1997 |
2 |
| 29 |
9131716 | Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro. | 1997 Mar |
1 |
| 30 |
9423940 | Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation. | 1997 Dec |
1 |
| 31 |
9477462 | Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits. | 1997 Dec |
1 |
| 32 |
8668917 | Heparin in clinical doses 'primes' granulocytes to subsequent activation as measured by myeloperoxidase release. | 1996 Apr |
1 |
| 33 |
8740352 | Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit. | 1996 Mar |
1 |
| 34 |
8864022 | Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery. | 1996 Sep |
1 |
| 35 |
8526620 | Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. | 1995 Nov |
1 |
| 36 |
8787476 | High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes. | 1995 Dec |
1 |
| 37 |
8067851 | Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. | 1994 Aug |
1 |
| 38 |
8389063 | The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes. | 1993 Mar 15 |
2 |
| 39 |
8406134 | Evidence for free radical formation during human kidney transplantation. | 1993 Sep |
2 |
| 40 |
6195265 | A mechanism for inhibition of luminol-dependent neutrophil chemiluminescence by polyanions. | 1983 Nov |
1 |